Suppr超能文献

AAV 介导的视蛋白基因增强对 P23H 视蛋白突变引起的 knock-in 小鼠模型中视网膜变性的影响。

Effect of AAV-Mediated Rhodopsin Gene Augmentation on Retinal Degeneration Caused by the Dominant P23H Rhodopsin Mutation in a Knock-In Murine Model.

机构信息

Nuffield Laboratory of Ophthalmology, John Radcliffe Hospital, Oxford, United Kingdom.

Moorfields Eye Hospital, London, United Kingdom.

出版信息

Hum Gene Ther. 2020 Jul;31(13-14):730-742. doi: 10.1089/hum.2020.008. Epub 2020 Jun 26.

Abstract

Mutations in the rhodopsin gene may cause photoreceptor degeneration in autosomal dominant retinitis pigmentosa (ADRP) by dominant negative or toxic gain-of-function mechanisms. Controversy exists as to the mechanism by which the widely studied P23H mutation induces rod cell dysfunction and death. Inherited disease caused by dominant negative mutations may be amenable to treatment using wild-type gene augmentation. Indeed, prior studies in the transgenic mouse model of ADRP have suggested that a therapeutic benefit may be achieved when wild-type rhodopsin is overexpressed following subretinal delivery of a recombinant adeno-associated viral (AAV) vector. In this study, we investigated the effect of wild-type rhodopsin supplementation on the rate of retinal degeneration in the more clinically relevant knock-in mouse model of ADRP. Four AAVs carrying the human rhodopsin coding sequence were first designed and compared for efficacy in the rhodopsin knockout mouse. All four vectors were capable of driving expression of the human transgene in the knockout retina with the protein being appropriately trafficked to rod outer segments. The most efficient of these vectors was injected at one of two doses into the subretinal space of mice and the effect on retinal structure and function determined longitudinally by spectral-domain optical coherence tomography and electroretinography, respectively, over a 3-month period. Although significant overexpression of rhodopsin protein was achieved in this model, no beneficial effect on retinal structure or function was observed at either dose. Lack of therapeutic efficacy in this model may be attributable to the relative rapidity of degeneration in the mouse relative to the human disease, over- or under dosing at the level of individual photoreceptors, late timing of the intervention, or a possible predominant toxic gain-of-function mechanism of degeneration.

摘要

视紫红质基因突变可能通过显性负性或毒性获得性功能机制导致常染色体显性遗传视网膜色素变性(ADRP)中的光感受器变性。广泛研究的 P23H 突变如何诱导杆状细胞功能障碍和死亡,其机制尚存在争议。由显性负性突变引起的遗传性疾病可能可以通过野生型基因增强来治疗。事实上,ADRP 的转基因小鼠模型中的先前研究表明,当通过重组腺相关病毒(AAV)载体进行视网膜下递送至野生型视紫红质过表达时,可能会获得治疗益处。在这项研究中,我们研究了在更具临床相关性的 ADRP 敲入小鼠模型中补充野生型视紫红质对视网膜变性速度的影响。首先设计了携带人类视紫红质编码序列的四个 AAV,并比较了它们在视紫红质敲除小鼠中的功效。所有四个载体均能够在敲除视网膜中驱动人类转基因的表达,并且蛋白质被适当运送到杆状细胞外段。这些载体中最有效的一种以两种剂量之一注射到视网膜下腔中,并通过光谱域光学相干断层扫描和视网膜电图分别在 3 个月的时间内纵向确定对视网膜结构和功能的影响。尽管在该模型中实现了视紫红质蛋白的显著过表达,但在两种剂量下均未观察到对视网膜结构或功能的有益作用。该模型中缺乏治疗功效可能归因于相对于人类疾病,在个体光感受器的水平上过度或剂量不足,干预的时间较晚,或可能存在主要的毒性获得性功能机制变性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验